Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract

Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1 Ajani, 2006, Aspirin use among U.S. adults: behavioral risk factor Surveillance system, Am J Prev Med, 1, 74, 10.1016/j.amepre.2005.08.042 National Health Service Information Centre, 2008 Weil, 1995, Prophylactic aspirin and risk of peptic ulcer bleeding, BMJ, 310, 827, 10.1136/bmj.310.6983.827 Yeomans, 2005, Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin, Aliment Pharmacol Ther, 22, 795, 10.1111/j.1365-2036.2005.02649.x Bhatt, 2008, ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol, 52, 1502, 10.1016/j.jacc.2008.08.002 Lanas, 2011, Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice, Expert Opin Drug Saf, 10, 45, 10.1517/14740338.2010.507629 Cayla, 2010, Prevalence and clinical impact of upper gastrointestinal symptoms in subjects treated with low dose aspirin: the UGLA survey, Int J Cardiol García Rodríguez, 2009, Discontinuation of low-dose acetylsalicylic acid treatment for secondary prevention of cardiovascular outcomes, Circulation, 120, S480 Collet, 2004, Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes, Circulation, 110, 2361, 10.1161/01.CIR.0000145171.89690.B4 Maulaz, 2005, Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke, Arch Neurol, 62, 1217, 10.1001/archneur.62.8.1217 Biondi-Zoccai, 2006, A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease, Eur Heart J, 27, 2667, 10.1093/eurheartj/ehl334 Rodríguez, 2011, Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care, BMJ, 343, d4094, 10.1136/bmj.d4094 Holtmann, 2002, Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?, Gastroenterology, 123, 1451, 10.1053/gast.2002.36556 Yeomans, 2011, Aspirin: old drug, new uses and challenges, J Gastroenterol Hepatol, 26, 426, 10.1111/j.1440-1746.2010.06569.x Geall, 1970, Profile of gastric potential difference in man. Effects of aspirin, alcohol, bile, and endogenous acid, Gastroenterology, 58, 437, 10.1016/S0016-5085(70)80057-9 Wallace, 1997, Inflammatory mediators in gastrointestinal defense and injury, Proc Soc Exp Biol Med, 214, 192, 10.3181/00379727-214-44087 Reuter, 1994, Markedly reduced intestinal toxicity of a diclofenac derivative, Life Sci, 55, PL1, 10.1016/0024-3205(94)90083-3 Capone, 2004, Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects, Circulation, 109, 1468, 10.1161/01.CIR.0000124715.27937.78 Capone, 2007, Pharmacodynamic of cyclooxygenase inhibitors in humans, Prostaglandins Other Lipid Mediat, 82, 85, 10.1016/j.prostaglandins.2006.05.019 Simmons, 2004, Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition, Pharmacol Rev, 56, 387, 10.1124/pr.56.3.3 Tomisato, 2004, Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions, Biochem Pharmacol, 67, 575, 10.1016/j.bcp.2003.09.020 Derry, 2000, Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis, BMJ, 321, 1183, 10.1136/bmj.321.7270.1183 Sørensen, 2000, Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin, Am J Gastroenterol, 95, 2218, 10.1111/j.1572-0241.2000.02248.x Kelly, 1996, Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product, Lancet, 348, 1413, 10.1016/S0140-6736(96)01254-8 Chowdhury, 2001, Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study, Indian J Gastroenterol, 20, 227 Garcia Rodriguez, 2001, Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies, Br J Clin Pharmacol, 52, 563, 10.1046/j.0306-5251.2001.01476.x Bjarnason, 2007, Determinants of the short term gastric damage caused by NSAIDs in man, Aliment Pharmacol Ther, 26, 95, 10.1111/j.1365-2036.2007.03348.x Darling, 2004, The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice, Gastroenterology, 127, 94, 10.1053/j.gastro.2004.04.003 Lichtenberger, 1985, Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa, Gastroenterology, 88, 308, 10.1016/S0016-5085(85)80185-2 Campbell, 2007, Aspirin dose for the prevention of cardiovascular disease: a systematic review, JAMA, 297, 2018, 10.1001/jama.297.18.2018 Cohen, 1982, Mechanism of aspirin injury to human gastroduodenal mucosa, Prostaglandins Leukot Med, 9, 241, 10.1016/0262-1746(82)90013-0 Hogan, 1994, Review article: gastroduodenal bicarbonate secretion, Aliment Pharmacol Ther, 8, 475, 10.1111/j.1365-2036.1994.tb00319.x Johansson, 1985, Protection of the gastroduodenal mucosa by prostaglandins, Scand J Gastroenterol Suppl, 110, 41, 10.3109/00365528509095830 Leivonen, 1992, Gastric changes in coronary-operated patients with low-dose aspirin, Scand J Gastroenterol, 27, 912, 10.3109/00365529209000162 Niv, 2005, Endoscopy in asymptomatic minidose aspirin consumers, Dig Dis Sci, 50, 78, 10.1007/s10620-005-1281-1 Sopeña, 2007, How to advise aspirin use in patients who need NSAIDs, Curr Pharm Des, 13, 2248, 10.2174/138161207781368837 Patrono, 2005, Low-dose aspirin for the prevention of atherothrombosis, N Engl J Med, 353, 2373, 10.1056/NEJMra052717 Capone, 2005, Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects, J Am Coll Cardiol, 45, 1295, 10.1016/j.jacc.2005.01.045 Catella-Lawson, 2001, Cyclooxygenase inhibitors and the antiplatelet effects of aspirin, N Engl J Med, 345, 1809, 10.1056/NEJMoa003199 Simon, 1995, Protective effect of omeprazol against low dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjects, Arzneimittelforshung, 45, 701 Muller, 1997, Studies on protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic. An endoscopic controlled double-blind study, Arzneimittelforshung, 47, 758 Hart, 2010, Predictors of gastroduodenal erosions in patients taking low-dose aspirin, Aliment Pharmacol Ther, 31, 143, 10.1111/j.1365-2036.2009.04133.x Laine, 2004, Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial, Gastroenterology, 127, 395, 10.1053/j.gastro.2004.05.001 Chan, 2002, Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial, Lancet, 359, 9, 10.1016/S0140-6736(02)07272-0 Moore, 2009, Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm, Clin Gastroenterol Hepatol, 7, 1156, 10.1016/j.cgh.2009.03.032 Fortun, 2005, Nonsteroidal antiinflammatory drugs and the small intestine, Curr Opin Gastroenterol, 21, 169, 10.1097/01.mog.0000153314.51198.58 Moore, 2008, Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes, Arthritis Res Ther, 10, R7, 10.1186/ar2355 Smecuol, 2009, Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment, Clin Gastroenterol Hepatol, 7, 524, 10.1016/j.cgh.2008.12.019 Hernández-Díaz, 2006, Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications, BMC Med, 4, 22, 10.1186/1741-7015-4-22 Lanas, 2000, Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding, N Engl J Med, 343, 834, 10.1056/NEJM200009213431202 Lanas, 2002, Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin, Aliment Pharmacol Ther, 16, 779, 10.1046/j.1365-2036.2002.01230.x Lanas, 2011, Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis, Clin Gastroenterol Hepatol, 9, 762, 10.1016/j.cgh.2011.05.020 Vist, 2005, Systematic review to determine whether participation in a trial influences outcome, BMJ, 330, 1175, 10.1136/bmj.330.7501.1175 Serrano, 2002, Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases, Aliment Pharmacol Ther, 16, 1945, 10.1046/j.1365-2036.2002.01355.x Laine, 2005, Bleeding complications related to aspirin dose, Am J Cardiol, 96, 1035, 10.1016/j.amjcard.2005.06.011 CURRENT-OASIS 7 Investigators, 2010, Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, N Engl J Med, 363, 930, 10.1056/NEJMoa0909475 Taha, 2008, Clinical trial: the incidence and early mortality after peptic ulcer perforation, and the use of low-dose aspirin and nonsteroidal anti-inflammatory drugs, Aliment Pharmacol Ther, 28, 878 Hoftiezer, 1980, Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man, Lancet, 2, 609, 10.1016/S0140-6736(80)90282-2 Sostres, 2009, Drug-related damage of the ageing gastrointestinal tract, Best Pract Res Clin Gastroenterol, 23, 849, 10.1016/j.bpg.2009.10.006 Lanas, 1992, Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding, Gastroenterology, 103, 862, 10.1016/0016-5085(92)90018-T Langman, 1985, Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage, Br Med J (Clin Res Ed), 290, 347, 10.1136/bmj.290.6465.347 Wilcox, 1997, Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding, Dig Dis Sci, 42, 990, 10.1023/A:1018832902287 Lanas, 1997, Evidence of aspirin use in both upper and lower gastrointestinal perforation, Gastroenterology, 112, 683, 10.1053/gast.1997.v112.pm9041228 Lanas, 2005, A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use, Am J Gastroenterol, 100, 1685, 10.1111/j.1572-0241.2005.41833.x Strate, 2011, Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding, Gastroenterology, 140, 1427, 10.1053/j.gastro.2011.02.004 Huang, 2010, Long-term use of aspirin and the risk of gastrointestinal bleeding in a prospective, population-based cohort, Gastroenterology, 138, 475e Zhao, 2008 Lanas, 2009, Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice, Am J Gastroenterol, 104, 1633, 10.1038/ajg.2009.164 Chan, 2008, Am J Gastroenterol, 103, 2908, 10.1111/j.1572-0241.2008.02200.x Pérez-Aisa, 2005, Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection, Aliment Pharmacol Ther, 21, 65, 10.1111/j.1365-2036.2004.02297.x Leontiadis, 2009, The role of proton pump inhibitors in the management of upper gastrointestinal bleeding, Gastroenterol Clin North Am, 38, 199, 10.1016/j.gtc.2009.03.008 Barkun, 2009, Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses, Gastrointest Endosc, 69, 786, 10.1016/j.gie.2008.05.031 Lanas, 2010, Editorial: upper GI bleeding-associated mortality: challenges to improving a resistant outcome, Am J Gastroenterol, 105, 90, 10.1038/ajg.2009.517 Shiotani, 2010, Aspirin-induced peptic ulcer and genetic polymorphisms, J Gastroenterol Hepatol, 25, S31, 10.1111/j.1440-1746.2009.06212.x Fiorucci, 2003, Gastrointestinal safety of NO-aspirin (NCX 4016) in healthy human volunteers: a proof of concept endoscopic study, Gastroenterology, 124, 600, 10.1053/gast.2003.50096 Goddard, 1995, In vitro recovery of canine gastric mucosal surface hydrophobicity and potential difference after aspirin damage, Dig Dis Sci, 40, 1357, 10.1007/BF02065551 Cryer, 2011, Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial, Am J Gastroenterol, 106, 272, 10.1038/ajg.2010.436